Literature DB >> 10475505

Outcome of patients undergoing transabdominal cerclage: a descriptive study.

M A Turnquest1, K A Britton, H L Brown.   

Abstract

OBJECTIVE: Transabdominal cerclage is now evolving as an alternative to transvaginal cerclage in patients with cervical incompetence. The purpose of our study was to evaluate and describe our experience in patients selected to undergo transabdominal cerclage placement.
METHODS: Outcome data for all patients who underwent transabdominal cerclage from January, 1990, through December, 1994, was collected. Indications for transabdominal cerclage included patients with prior failed vaginal cerclage, extremely shortened cervix, or anatomical defects judged unsuitable for transvaginal cerclage.
RESULTS: Eleven patients underwent 12 transabdominal cerclage procedures. The mean gestational age at the time of cerclage placement was 12.5 weeks (range 10-14 weeks). The mean gestational age at delivery was 34 weeks. There were two neonatal deaths, which were related to extreme prematurity. The mean birthweight was 2,622 g. The fetal salvage rate was 83%.
CONCLUSIONS: These findings suggest that in a highly select group of patients, the transabdominal cerclage can be a safe and effective procedure.

Entities:  

Mesh:

Year:  1999        PMID: 10475505     DOI: 10.1002/(SICI)1520-6661(199909/10)8:5<225::AID-MFM5>3.0.CO;2-E

Source DB:  PubMed          Journal:  J Matern Fetal Med        ISSN: 1057-0802


  3 in total

1.  Transvaginal sonography and fiberoptic illumination of uterine vessels for abdominal cervicoisthmic cerclage.

Authors:  Olufemi Olatunbosun; Roger Turnell; Roger Pierson
Journal:  Obstet Gynecol       Date:  2003-11       Impact factor: 7.661

Review 2.  Robotic-assisted abdominal cerclage: a case report and literature review.

Authors:  Gulden Menderes; Lindsay Clark; Masoud Azodi
Journal:  J Robot Surg       Date:  2014-04-30

3.  Prediction of outcome for transabdominal cerclage in women with cervical insufficiency.

Authors:  Ji Eun Song; Keun Young Lee; Ga Hyun Son
Journal:  Biomed Res Int       Date:  2015-02-25       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.